Peng Yuan1, Cheng Zhao1, Zhizhong Liu2, Zhenyu Ou1, Wei He1, Yuxiang Cai3, Yu Wang4, Xiongbin Zu1, Lin Qi1, Long Wang1. 1. 1 Department of Urology, Xiangya Hospital, Central South University , Changsha, China . 2. 2 Department of Urology, Hunan Provincial Tumor Hospital and Affiliated Tumor Hospital of Xiangya Medical School, Central South University , Changsha, China . 3. 3 Department of Pathology, Xiangya Hospital, Central South University , Changsha, China . 4. 4 Department of Science and Technology, UPS Biological Technology Corporation , Changsha, China .
Abstract
OBJECTIVE: To compare the efficacy and safety of video endoscopic inguinal lymphadenectomy through a hypogastric subcutaneous approach (VEIL-H) with a leg subcutaneous approach (VEIL-L) in the surgical management of penile cancer. MATERIALS AND METHODS: Between October 2012 and October 2016, 72 penile cancer patients who underwent VEIL-H (n = 37) or VEIL-L (n = 35) by one experienced surgeon in our hospital were retrospectively included. Data associated with demographic characteristics and perioperative outcomes were evaluated and compared between two groups. RESULTS: No intraoperative complications occurred and no deaths were recorded. No difference was noted with respect to demographic and clinicopathological data, operative time, estimated blood loss, spare of the great saphenous vein, dissected inguinal lymph nodes, patients with inguinal lymph node metastasis, positive inguinal lymph nodes, duration of drain, postoperative hospital days, and postoperative complications between two groups (p > 0.05). Two patients of each group received a bilateral laparoscopic pelvic lymphadenectomy in one session. The pathological results of all dissected pelvic lymph nodes were negative. Median follow-up was 16.2 months, during which time three patients in VEIL-L group and two patients in VEIL-H group developed regional or distant metastases. CONCLUSIONS: Hypogastric approach is as effective and safe as VEIL-L for penile cancer. Moreover, VEIL-H can avoid the operation on both the limb and abdomen if laparoscopic pelvic lymphadenectomy is required.
OBJECTIVE: To compare the efficacy and safety of video endoscopic inguinal lymphadenectomy through a hypogastric subcutaneous approach (VEIL-H) with a leg subcutaneous approach (VEIL-L) in the surgical management of penile cancer. MATERIALS AND METHODS: Between October 2012 and October 2016, 72 penile cancerpatients who underwent VEIL-H (n = 37) or VEIL-L (n = 35) by one experienced surgeon in our hospital were retrospectively included. Data associated with demographic characteristics and perioperative outcomes were evaluated and compared between two groups. RESULTS: No intraoperative complications occurred and no deaths were recorded. No difference was noted with respect to demographic and clinicopathological data, operative time, estimated blood loss, spare of the great saphenous vein, dissected inguinal lymph nodes, patients with inguinal lymph node metastasis, positive inguinal lymph nodes, duration of drain, postoperative hospital days, and postoperative complications between two groups (p > 0.05). Two patients of each group received a bilateral laparoscopic pelvic lymphadenectomy in one session. The pathological results of all dissected pelvic lymph nodes were negative. Median follow-up was 16.2 months, during which time three patients in VEIL-L group and two patients in VEIL-H group developed regional or distant metastases. CONCLUSIONS: Hypogastric approach is as effective and safe as VEIL-L for penile cancer. Moreover, VEIL-H can avoid the operation on both the limb and abdomen if laparoscopic pelvic lymphadenectomy is required.
Entities:
Keywords:
hypogastric subcutaneous approach; penile cancer; video endoscopic inguinal lymphadenectomy
Authors: Christian D Fankhauser; Esther W C Lee; Allaudin Issa; Pedro Oliveira; Maurice Lau; Vijay Sangar; Arie Parnham Journal: Eur Urol Open Sci Date: 2021-11-18
Authors: A Gómez-Ferrer; A Collado; M Ramírez; J Domínguez; J Casanova; C Mir; A Wong; J L Marenco; E Nagore; V Soriano; J Rubio-Briones Journal: Front Surg Date: 2022-09-26